PP
RXST icon

PDT Partners’s RxSight RXST Stock Holding History

PDT Partners’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-26,521
Closed -$163K – 596
2026
Q1 		$163K Sell
26,521
-56,318
-68% -$468K 0.01% 508
2025
Q4 		$863K Sell
82,839
-6,785
-8% -$68.1K 0.06% 359
2025
Q3 		$806K Hold
89,624
– – 0.05% 383
2025
Q2 		$1.17M Buy
+89,624
New +$1.35M 0.07% 398
2025
Q1 		– Sell
-26,245
Closed -$902K – 841
2024
Q4 		$902K Buy
26,245
+8,116
+45% +$366K 0.08% 359
2024
Q3 		$896K Buy
+18,129
New +$929K 0.08% 387

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

PDT Partners's RXST Position: Q2 2026 in Review

PDT Partners sold out of RxSight (RXST) in Q2 2026, closing a stake of 26,521 shares — an estimated $163K sold.

PDT Partners first reported a position in RXST in Q3 2024 and held it in 6 quarters. The position peaked at $1.17M in Q2 2025. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • PDT Partners reported no remaining RxSight position as of Q2 2026 after selling out during the quarter.
  • PDT Partners sold 26,521 RxSight shares in Q2 2026, an estimated $163K.
  • PDT Partners first reported a position in RxSight in Q3 2024 and held it in 6 quarters.
  • PDT Partners's RxSight position peaked at $1.17M in Q2 2025.
  • 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on PDT Partners's 13F filing for Q2 2026, filed 14 Aug 2026.